WCLC Updates in Small Cell Lung Cancer

EP: 1.WCLC Updates in KRAS and Rare EGFR-Mutated NSCLC

EP: 2.WCLC Updates on the Emergence of ADCs in NSCLC

EP: 3.WCLC Updates in Immunotherapy for NSCLC

EP: 4.WCLC Updates in Neoadjuvant Therapy for NSCLC

EP: 5.WCLC Updates in Locally Advanced NSCLC

Now Viewing

EP: 6.WCLC Updates in Small Cell Lung Cancer

Data from the following clinical trials are discussed:

• P15.01 - AMG 757, a Half-life Extended Bispecific T-Cell Engager (HLE BiTE® Immune Therapy) Targeting DLL3, for the Treatment of Small Cell Lung Cancer
• OA11.04 - Lurbinectedin With Irinotecan in Relapsed Small Cell Lung Cancer. Results From the Expansion Stage of a Phase I/II Trial